Sotera Health Co. (SHC)
16.27
-0.34
(-2.05%)
USD |
NASDAQ |
Nov 16, 16:00
16.27
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Enterprise Value : 6.607B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.607B |
| November 12, 2026 | 6.519B |
| November 11, 2026 | 6.559B |
| November 10, 2026 | 6.510B |
| November 09, 2026 | 6.559B |
| November 06, 2026 | 6.436B |
| November 05, 2026 | 6.396B |
| November 04, 2026 | 6.544B |
| November 03, 2026 | 6.442B |
| November 02, 2026 | 6.930B |
| October 30, 2026 | 7.047B |
| October 29, 2026 | 7.204B |
| October 28, 2026 | 7.190B |
| October 27, 2026 | 7.144B |
| October 26, 2026 | 7.116B |
| October 23, 2026 | 7.033B |
| October 22, 2026 | 7.041B |
| October 21, 2026 | 6.938B |
| October 20, 2026 | 6.984B |
| October 19, 2026 | 6.901B |
| October 16, 2026 | 6.973B |
| October 15, 2026 | 7.024B |
| October 14, 2026 | 6.927B |
| October 13, 2026 | 7.064B |
| October 12, 2026 | 7.047B |
| Date | Value |
|---|---|
| October 09, 2026 | 7.021B |
| October 08, 2026 | 6.956B |
| October 07, 2026 | 6.976B |
| October 06, 2026 | 7.076B |
| October 05, 2026 | 7.161B |
| October 02, 2026 | 7.067B |
| October 01, 2026 | 7.038B |
| September 30, 2026 | 7.144B |
| September 29, 2026 | 7.219B |
| September 28, 2026 | 7.176B |
| September 25, 2026 | 7.145B |
| September 24, 2026 | 7.176B |
| September 23, 2026 | 7.131B |
| September 22, 2026 | 7.245B |
| September 21, 2026 | 7.248B |
| September 18, 2026 | 7.256B |
| September 17, 2026 | 7.319B |
| September 16, 2026 | 7.427B |
| September 15, 2026 | 7.328B |
| September 14, 2026 | 7.196B |
| September 11, 2026 | 7.153B |
| September 10, 2026 | 7.122B |
| September 09, 2026 | 7.142B |
| September 08, 2026 | 7.216B |
| September 04, 2026 | 7.305B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ginkgo Bioworks Holdings, Inc. | 700.96M |
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
| Myriad Genetics, Inc. | 643.96M |
| OPKO Health, Inc. | 1.321B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 58.39M |
| Revenue (Quarterly) | 324.89M |
| Total Expenses (Quarterly) | 266.50M |
| EPS Diluted (Quarterly) | 0.2019 |
| Gross Profit Margin (Quarterly) | 54.72% |
| Profit Margin (Quarterly) | 17.97% |
| Earnings Yield | 3.70% |
| Operating Earnings Yield | 9.62% |
| Normalized Earnings Yield | 4.443 |